Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

OMAR ALKHARABSHEH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1306124813
CMS profile
240635
Location
CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,927.87

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,901.65 114
Education $26.22 1

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

OMAR ALKHARABSHEH

NPI 1306124813 · CMS profile ID 240635

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CINCINNATI, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306124813?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
OMAR ALKHARABSHEH, NPI 1306124813, CMS profile ID 240635. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306124813?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). OMAR ALKHARABSHEH, NPI 1306124813, CMS profile ID 240635. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306124813?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
OMAR ALKHARABSHEH, NPI 1306124813, CMS profile ID 240635, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1306124813?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $1,927.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $13.3108/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949355959 CMS
Karyopharm Therapeutics Inc. $12.1408/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946525797 CMS
Novartis Pharmaceuticals Corporation $15.8408/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495753 CMS
Celgene Corporation $17.9108/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768863 CMS
AstraZeneca Pharmaceuticals LP $18.2708/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915296602 CMS
Celgene Corporation $14.8008/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768865 CMS
EMD Serono, Inc. $12.7807/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941544193 CMS
GENZYME CORPORATION $17.0307/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939029995 CMS
Myovant Sciences Inc. $12.7507/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941176387 CMS
Amgen Inc. $16.2707/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939923123 CMS
Janssen Biotech, Inc. $25.1907/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885478927 CMS
Novartis Pharmaceuticals Corporation $23.8807/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495743 CMS
Novartis Pharmaceuticals Corporation $16.6607/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495749 CMS
Janssen Biotech, Inc. $17.2207/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885478943 CMS
Amgen Inc. $17.2007/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939923131 CMS
Amgen Inc. $10.4707/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939404287 CMS
BeiGene USA, Inc. $13.8107/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940788425 CMS
Epizyme, Inc., $14.2006/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917605601 CMS
EISAI INC. $19.5606/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908072331 CMS
Amgen Inc. $14.2606/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939923121 CMS
Gilead Sciences, Inc. $17.1606/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929600413 CMS
Novartis Pharmaceuticals Corporation $21.9406/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495739 CMS
Incyte Corporation $13.3406/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943025871 CMS
Novartis Pharmaceuticals Corporation $17.5406/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495731 CMS
Amgen Inc. $14.3506/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939923129 CMS
Celgene Corporation $17.0106/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768851 CMS
Pharmacosmos Therapeutics Inc. $18.5806/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959137721 CMS
Janssen Biotech, Inc. $18.6705/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885478949 CMS
Regeneron Healthcare Solutions, Inc. $24.5505/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927097919 CMS
Novartis Pharmaceuticals Corporation $23.1805/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495727 CMS
Sobi, Inc $14.2705/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940377835 CMS
Celgene Corporation $16.8905/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768839 CMS
Novartis Pharmaceuticals Corporation $20.8805/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495735 CMS
Celgene Corporation $2.6905/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768843 CMS
Celgene Corporation $6.1305/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768845 CMS
Regeneron Healthcare Solutions, Inc. $26.5005/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927097917 CMS
ABBVIE INC. $24.0105/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890487683 CMS
Rigel Pharmaceuticals, Inc. $16.8005/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962268561 CMS
Novartis Pharmaceuticals Corporation $10.3305/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495721 CMS
Celgene Corporation $2.9904/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768831 CMS
Celgene Corporation $8.2504/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768833 CMS
ARRAY BIOPHARMA INC $13.9604/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949127425 CMS
AstraZeneca Pharmaceuticals LP $23.4504/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914650173 CMS
Novartis Pharmaceuticals Corporation $19.7404/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893495717 CMS
Epizyme, Inc., $12.2603/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917605593 CMS
Celgene Corporation $15.6903/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768821 CMS
Amgen Inc. $14.4303/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939923119 CMS
Celgene Corporation $9.7003/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932768827 CMS
PFIZER INC. $20.0703/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949490687 CMS
EISAI INC. $14.6103/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908072315 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $492.28 17
PY2020 $13,369.57 42
PY2021 $3,017.99 14
PY2022 $1,927.87 115
PY2023 $4,084.87 124
PY2024 $4,233.89 110
PY2025 $5,141.91 73

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $398,649.15 11
PY2024 Principal investigator $340,129.64 8
PY2023 Principal investigator $265,182.52 25
PY2022 Recipient $8.00 1
PY2022 Principal investigator $85,310.00 9
PY2021 Principal investigator $19,170.00 4
PY2020 Principal investigator $40,980.00 2
PY2019 Principal investigator $542.65 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 BeOne Medicines USA, Inc. $611.00 12/30/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190333008
Principal investigator 1 BeOne Medicines USA, Inc. $750.00 09/02/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190328261
Principal investigator 1 BeOne Medicines USA, Inc. $611.00 09/02/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190333001
Principal investigator 1 BeOne Medicines USA, Inc. $400.00 08/19/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190328263
Principal investigator 1 BeOne Medicines USA, Inc. $1,355.00 07/29/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190333003
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $6,500.00 06/24/2025 Non-covered Recipient Entity
UNIVERSITY OF SOUTH ALABAMA
AN OPEN-LABEL, MULTICENTER PHASE 1B STUDY INVESTIGATING THE SAFETY OF TAK-079 IN COMBINATION WITH BACKBONE REGIMENS FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AND FOR WHOM STEM CELL TRANSPLANTATION IS NOT PLANNED AS INITIAL THERAPY No dispute reported 06/30/2026 1223281808
Principal investigator 1 Eli Lilly and Company $145.40 05/08/2025 Covered Recipient Teaching Hospital
USA HEALTH UNIVERSITY HOSPITAL
STUDY OF LOXO-305 VERSUS INVESTIGATOR'S CHOICE (IDELAR OR BR) IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) (BRUIN CLL-321) No dispute reported 06/30/2026 1187875363
Principal investigator 1 BeiGene USA, Inc. $750.00 01/28/2025 Non-covered Recipient Entity
South Alabama Medical Science Foundation
A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia No dispute reported 06/30/2026 1190320370
Principal investigator 1 Eli Lilly and Company $10,714.34 01/28/2025 Covered Recipient Teaching Hospital
USA HEALTH UNIVERSITY HOSPITAL
STUDY OF LOXO-305 VERSUS INVESTIGATOR'S CHOICE (IDELAR OR BR) IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) (BRUIN CLL-321) No dispute reported 06/30/2026 1187875361
Principal investigator 2 E.R. Squibb & Sons, L.L.C. $7,561.29 01/27/2025 Non-covered Recipient Entity
Usa Mitchell Cancer Institute
A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING CC-92480 (BMS-986348), CARFILZOMIB AND DEXAMETHASONE (480Kd) VERSUS CARFILZOMIB AND DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM). No dispute reported 06/30/2026 1235992117
Principal investigator 2 E.R. Squibb & Sons, L.L.C. $369,251.12 01/27/2025 Covered Recipient Teaching Hospital
Usa Health University Hospital
A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING CC-92480 (BMS-986348), CARFILZOMIB AND DEXAMETHASONE (480Kd) VERSUS CARFILZOMIB AND DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM). No dispute reported 06/30/2026 1235999642